Return to Listing

1 result(s) for

PI Name Protocol # Title
Aimee Kohn STUDY00019746 A Phase 2 Randomized Study of Adjuvant Immunotherapy With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080